These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5074361)

  • 1. Effect of L-dihydroxyphenylalanine upon serum growth hormone concentrations in children and adolescents.
    Root AW; Russ RD
    J Pediatr; 1972 Oct; 81(4):808-13. PubMed ID: 5074361
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma growth hormone and insulin response to levodopa and amantadine.
    Kytömäki O; Nousiainen R; Pekkarinen A; Rinne UK; Viljanen M
    J Neural Transm; 1973; 34(2):145-51. PubMed ID: 4722572
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of L-dopa on anterior pituitary hormone release in man.
    Saito S; Abe K; Nagata N; Nakamura E; Tanaka K
    Endocrinol Jpn; 1972 Oct; 19(5):435-42. PubMed ID: 4678853
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of L-dopa and chlorpromazine on human growth hormone and TSH secretion in normal subjects and acromegalics.
    Singh P; McDevitt DG; Mackay J; Hadden DR
    Horm Res; 1973; 4(5):293-301. PubMed ID: 4755420
    [No Abstract]   [Full Text] [Related]  

  • 5. The levodopa test of growth hormone reserve in children.
    Porter BA; Rosenfield RL; Lawrence AM
    Am J Dis Child; 1973 Nov; 126(5):589-92. PubMed ID: 4200807
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of human growth hormone, follicle stimulating hormone, and luteinizing hormone in response to L-dihydroxy-phenylalanine (L-dopa) in normal man.
    Perlow MJ; Sassin JF; Boyar R; Hellman L; Weitzman ED
    Dis Nerv Syst; 1972 Dec; 33(12):804-10. PubMed ID: 4668972
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients.
    Cavagnini F; Peracchi M; Scotti G; Raggi U; Pontiroli AE; Bana R
    J Endocrinol; 1972 Sep; 54(3):425-33. PubMed ID: 5071365
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
    Cavagnini F; Pontiroli AE; Raggi U; Peracchi M; Malinverni A
    Folia Endocrinol; 1973 Dec; 26(6):483-9. PubMed ID: 4801258
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of L-dopa on plasma growth hormone, insulin, and thyroxine.
    Kansal PC; Buse J; Talbert OR; Buse MG
    J Clin Endocrinol Metab; 1972 Jan; 34(1):99-105. PubMed ID: 5061778
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticosteroid and growth hormone secretion in patients treated with L-dopa.
    von Werder K; van Loon GR; Yatsu F; Forsham PH
    Klin Wochenschr; 1970 Dec; 48(24):1454-6. PubMed ID: 4324569
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of insulin release and stimulation of growth hormone release by hypocalcemia in a boy.
    Laron Z; Rosenberg T
    Horm Metab Res; 1970 Mar; 2(2):121-2. PubMed ID: 5520907
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ageing on insulin and growth hormone response to glucose and arginine in normal subjects.
    Viberti G; Pontiroli AE; Mignani E; Tognetti A; Marigo S; Pozza G
    Acta Diabetol Lat; 1974; 11(6):432-6. PubMed ID: 4620121
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of L-dopa on pituitary TSH and GH secretion in Parkinson's disease].
    Sakoda M; Kusaka T; Baba S; Shirakata S
    Nihon Naibunpi Gakkai Zasshi; 1972 Jul; 48(4):241-4. PubMed ID: 5066290
    [No Abstract]   [Full Text] [Related]  

  • 14. L-dopa induced growth hormone secretion. Comparison with insulin tolerance test, arginine infusion and sleep induced GH-secretion.
    Lucke C; Höffken B; Morgner KD
    Acta Endocrinol (Copenh); 1974 Oct; 77(2):241-9. PubMed ID: 4479561
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating levels of anterior pituitary hormones and insulin after arginine infusion.
    Cremer GM; Bilstad JM; Faiman C; Moxness KE
    Mayo Clin Proc; 1968 Nov; 43(11):776-82. PubMed ID: 4885979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Obesity and the somatotropic hormone. I. Somatotropin secretion in obesity].
    Giordano G; Foppiani E; Minuto F; Marugo M
    Folia Endocrinol; 1974 Aug; 27(4):339-68. PubMed ID: 4408078
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum prolactin levels in humans from birth to adult life.
    Guyda HJ; Friesen HG
    Pediatr Res; 1973 May; 7(5):534-40. PubMed ID: 4704745
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes of somatotropinemia in patients with acromegaly following administration of L-dopa].
    Chiodini PG; Liuzzi A; Cremascoli G; Botalla L
    Folia Endocrinol; 1973 Dec; 26(6):497-502. PubMed ID: 4801260
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of L-dopa on plasma growth hormones and insulin.
    Kytomaki O; Nousiainen R; Pekkarinen A; Rinne U; Siirtola T; Sonninen V; Viljanen M
    Acta Neurol Scand Suppl; 1972; 51():125-6. PubMed ID: 4514338
    [No Abstract]   [Full Text] [Related]  

  • 20. L-DOPA and pituitary hormone secretion.
    Hayek A; Crawford JD
    J Clin Endocrinol Metab; 1972 May; 34(5):764-6. PubMed ID: 5012491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.